cabeyond: cabozantinib beyond pd and survival outcomes in mrcc
Published 3 years ago • 90 plays • Length 3:24Download video MP4
Download video MP3
Similar videos
-
2:40
updates on the cabopre phase ii trial in patients with metastatic renal cell carcinoma
-
0:48
clinical activity of cabozantinib in patients with rcc with brain metastases
-
1:36
cabozantinib in patients with hcc refractory to checkpoint inhibitors
-
1:26
neoadjuvant cabozantinib in patients with locally advanced non-metastatic ccrcc
-
0:50
cassiope: cabozantinib in the real-word for rcc
-
1:20
promising results of cabozantinib plus nivolumab in non-clear cell rcc
-
1:12
cabozantinib for advanced renal cell carcinoma: the meteor and cabosun trials
-
1:45
real-world outcomes of mrcc in the current io & tki era
-
2:02
cabozantinib in mrcc
-
2:47
cabozantinib in mrcc
-
1:23
checkmate 9er: nivolumab with cabozantinib in renal cell carcinoma
-
0:52
dr. choueiri on the role of cabozantinib in rcc
-
0:41
dr. toni choueiri on cabozantinib and nivolumab combination in kidney cancer
-
0:29
dr. mckay on fda approval of frontline cabozantinib in rcc
-
1:52
efficacy of targeted therapies after pd-1/pd-l1 blockade in metastatic renal cell carcinoma
-
2:32
case of combination cabozantinib nivolumab for progressive metastatic renal cell carcinoma (mrcc)
-
6:37
cabozantinib in combination with nivolumab demonstrated continued survival and hrqol in arcc pat...
-
6:30
cabozantinib plus nivolumab for first-line mrcc
-
5:49
cabozantinib improves advanced kidney cancer survival: meteor trial results